Raymond James Financial Portfolio holdings
Raymond James Financial, founded in 1962 by Robert James and headquartered in St. Petersburg, Florida, is a diversified financial services firm managing over $1.5 trillion in client assets as of late 2024, primarily focused on wealth management, investment banking, and brokerage services. Known for its advisor-centric model, the firm supports over 8,900 financial advisors across the U.S., Canada, and the UK, offering personalized financial planning, retirement solutions, and investment products to individuals, small businesses, and institutions. Its investment banking arm specializes in middle-market mergers, acquisitions, and equity offerings, while its Raymond James Bank provides lending and deposit services. With a reputation for a conservative, client-first culture and steady growth—including a notable acquisition of TriState Capital in 2022—Raymond James stands out as a resilient, relationship-driven player in the financial industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$962M |
| 2 |
AbbVie
ABBV
|
+$512M |
| 3 |
Bank of America
BAC
|
+$172M |
| 4 |
TJX Companies
TJX
|
+$157M |
| 5 |
GE Vernova
GEV
|
+$156M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$636M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$388M |
| 3 |
Palantir
PLTR
|
+$253M |
| 4 |
Applovin
APP
|
+$236M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$212M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 39.84% |
| 2 | Technology | 16.54% |
| 3 | Financials | 9.27% |
| 4 | Industrials | 6.9% |
| 5 | Healthcare | 6.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
NXC
4326
DELISTED
Nuveen CA Select Tax-Free Income Portfolio
NXC
| $281K | ﹤0.01% |
21,331
+64
| +0.3% | +$821 |
2024 Q4
2 quarters
|
|
4327
OneWater Marine
ONEW
$161M
| $280K | ﹤0.01% |
20,948
+10,189
| +95% | +$145K |
2024 Q4
2 quarters
|
|
|
LENZ
4328
LENZ Therapeutics
LENZ
$119M
| $280K | ﹤0.01% |
9,561
| – | – |
2024 Q4
2 quarters
|
|
4329
Innovator Emerging Markets Power Buffer ETF July
EJUL
$213M
| $280K | ﹤0.01% |
10,101
-11,494
| -53% | -$297K |
2024 Q4
2 quarters
|
|
4330
Macy's
M
$5.94B
| $279K | ﹤0.01% |
23,949
+1,040
| +5% | +$12.1K |
2024 Q4
2 quarters
|
|
|
XHR
4331
Xenia Hotels & Resorts
XHR
$1.67B
| $279K | ﹤0.01% |
22,167
-189
| -0.8% | -$2.16K |
2024 Q4
2 quarters
|
|
4332
ReposiTrak
TRAK
$152M
| $279K | ﹤0.01% |
14,174
+495
| +4% | +$10.4K |
2025 Q1
1 quarter
|
|
|
EBTC
4333
DELISTED
Enterprise Bancorp
EBTC
| $278K | ﹤0.01% |
7,024
| – | – |
2024 Q4
2 quarters
|
|
4334
Northeast Bank
NBN
$1.07B
| $278K | ﹤0.01% |
3,125
| – | – |
2024 Q4
2 quarters
|
|
4335
BondBloxx Bloomberg One Year Target Duration US Treasury ETF
XONE
$858M
| $277K | ﹤0.01% |
+5,587
| New | +$277K |
2025 Q2
0 quarters
|
|
4336
Burford Capital
BUR
$839M
| $277K | ﹤0.01% |
+19,441
| New | +$254K |
2025 Q2
0 quarters
|
|
4337
Invesco FTSE RAFI Developed Markets ex-US Small-Mid ETF
PDN
$346M
| $277K | ﹤0.01% |
7,121
+8
| +0.1% | +$287 |
2024 Q4
2 quarters
|
|
4338
CVR Partners
UAN
$1.32B
| $277K | ﹤0.01% |
3,119
| – | – |
2024 Q4
2 quarters
|
|
4339
PUT
AT&T
T
$167B
| $276K | ﹤0.01% |
13,200
-300
| -2% | -$8.27K |
2024 Q4
2 quarters
|
|
4340
State Street SPDR S&P Oil & Gas Equipment & Services ETF
XES
$356M
| $276K | ﹤0.01% |
4,348
-195
| -4% | -$12K |
2024 Q4
2 quarters
|
|
|
DSM
4341
BNY Mellon Strategic Municipal Bond Fund
DSM
$257M
| $275K | ﹤0.01% |
49,189
+1,674
| +4% | +$9.39K |
2024 Q4
2 quarters
|
|
|
RMMZ
4342
RiverNorth Managed Duration Municipal Income Fund II
RMMZ
$111M
| $275K | ﹤0.01% |
19,581
-5,645
| -22% | -$80.9K |
2024 Q4
2 quarters
|
|
4343
Progyny
PGNY
$1.91B
| $275K | ﹤0.01% |
+12,504
| New | +$274K |
2025 Q2
0 quarters
|
|
4344
PUT
Vanguard Morningstar Total Stock Market ETF
VTI
$685B
| $275K | ﹤0.01% |
1,100
| – | – |
2025 Q1
1 quarter
|
|
|
HEQ
4345
John Hancock Hedged Equity & Income Fund
HEQ
$131M
| $275K | ﹤0.01% |
25,951
-122
| -0.5% | -$1.26K |
2024 Q4
2 quarters
|
|
4346
WhiteHorse Finance
WHF
$147M
| $274K | ﹤0.01% |
31,477
-7,729
| -20% | -$71.2K |
2024 Q4
2 quarters
|
|
4347
Sportradar
SRAD
$3.51B
| $274K | ﹤0.01% |
+9,764
| New | +$232K |
2025 Q2
0 quarters
|
|
4348
Bank7 Corp
BSVN
$524M
| $273K | ﹤0.01% |
+6,524
| New | +$248K |
2025 Q2
0 quarters
|
|
4349
Fidelity International High Dividend ETF
FIDI
$376M
| $273K | ﹤0.01% |
11,711
+1,398
| +14% | +$31.4K |
2024 Q4
2 quarters
|
|
|
CGO
4350
Calamos Global Total Return Fund
CGO
$124M
| $273K | ﹤0.01% |
23,275
-2,254
| -9% | -$24.2K |
2024 Q4
2 quarters
|
|
Similar funds
Raymond James Financial's Q2 2025 Portfolio in Review
As of Q2 2025, Raymond James Financial held 7,081 positions worth $290B, up 9.4% from $266B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Raymond James Financial's Q2 2025 filing shows 2,183 new, 2,404 increased, 2,172 reduced and 80 closed positions. Its largest new stake was ServiceTitan Inc: 369,922 shares worth $39.6M. The largest sale was Merck, an estimated $636M.
By sector, the portfolio is most concentrated in Miscellaneous at 40% of assets, down from 40% a quarter earlier, followed by Technology and Financials.
- Raymond James Financial's largest Q2 2025 buy was ServiceTitan Inc: 369,922 shares worth $39.6M.
- Raymond James Financial added most to Vanguard S&P 500 ETF in Q2 2025, an estimated $962M increase.
- Raymond James Financial's biggest Q2 2025 reduction was Merck, cutting an estimated $636M.
- Raymond James Financial fully exited Discover Financial Services in Q2 2025, selling an estimated $36.8M.
- Raymond James Financial's ten largest holdings make up 22% of its $290B portfolio in Q2 2025.
- Raymond James Financial opened 2,183 new positions and closed 80 in Q2 2025.
- Raymond James Financial's portfolio value rose 9.4% quarter-over-quarter to $290B.
Based on Raymond James Financial's 13F filing for Q2 2025, filed 14 Aug 2025.